NCT04890028: Detection and Metabolic Characterization in DOPA PET/CT of Brain Metastases

NCT04890028
Breast Cancer Type: HER2+, HR+ & HER2-negative, Triple Negative
Hormone Mutations: ER+, PR+
Other Mutations: 
Breast Cancer Tissue: 
Recruitment Status: Not yet recruiting
Not Applicable
Drug Category: Other

Key Eligibility Criteria:

Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases: Brain
Additional Notes: Patients must have at least one brain metastases that measures 5 mm
Exclusions: Patients with a history of brain radiation or surgery
https://ClinicalTrials.gov/show/NCT04890028

Comments are closed.

Up ↑